Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.
The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.
Highlights from Ardent Health's Q4 2024 results:
In addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.
Ardent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.